2023年中国眼镜行业年度盘点：稳健增长与创新突破
编者按：回顾2023年，眼镜行业在不确定性中稳步发展。本文将通过年度盘点，梳理行业热点与重点事件，探索增长周期中的关键因素。
Editor's Note: Looking back at 2023, the eyewear industry has shown steady development amidst uncertainties. This annual review will analyze industry hotspots and key events to identify growth drivers.
外贸表现：新兴市场成为新增长点
Foreign Trade: Emerging Markets as New Growth Drivers
2023年，中国眼镜产品出口额达572.43亿元人民币，同比增长6.2%。值得注意的是，对东盟国家出口增长8.23%，对俄罗斯出口更是激增90%。
In 2023, China's eyewear exports reached 57.243 billion yuan, up 6.2% year-on-year. Notably, exports to ASEAN countries grew by 8.23%, while exports to Russia surged by 90%.
零售趋势：功能性镜片引领增长
Retail Trends: Functional Lenses Drive Growth
博士眼镜财报显示，2023年前三季度营收增长23.85%，净利润翻倍。近视管理镜片销量同比增长93.77%，成为主要增长动力。
Boshi Eyewear's financial report shows a 23.85% revenue growth and doubled net profit in the first three quarters. Myopia control lenses sales surged 93.77% year-on-year, becoming the main growth driver.
产品创新：高端镜片市场扩张
Product Innovation: High-end Lenses Market Expansion
明月镜片前三季度营收增长23.8%，功能性镜片占比持续提升。康耐特光学1.74高折射率镜片营收增长23.1%，显示高端产品需求旺盛。
Mingyue Lenses achieved 23.8% revenue growth with increasing functional lenses share. Conant Optical's 1.74 high-index lenses sales grew 23.1%, indicating strong demand for premium products.
眼科服务：资本市场新宠
Ophthalmology Services: Capital Market's New Favorite
2023年眼科领域融资超11亿元。爱尔眼科前三季度营收160.47亿元，增长22.95%；普瑞眼科净利润同比增长237.48%。
The ophthalmology sector raised over 1.1 billion yuan in 2023. Aier Eye Hospital's revenue reached 16.047 billion yuan (up 22.95%), while Puray's net profit surged 237.48%.
展望未来：随着技术进步和市场深化，眼镜行业将迎来更多创新机遇。产品升级、渠道创新和眼健康意识提升将继续推动行业发展。
Looking Ahead: With technological advancements and market development, the eyewear industry will see more innovation opportunities. Product upgrades, channel innovation and growing eye health awareness will continue driving industry growth.
